Belgium vs El Salvador: The number of people with susceptibility test result for rifampicin
Belgium
377
in 2021
El Salvador
316
in 2021
Belgium rank
86th
El Salvador rank
87th
The number of people with susceptibility test result for rifampicin over time
- Belgium
- El Salvador
How they compare
Belgium currently reports 377 against 316 in El Salvador, a difference of 61.
That makes Belgium's figure about 1.2 times El Salvador's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was El Salvador ahead.
Belgium ranks 86th and El Salvador ranks 87th of 155 countries.
El Salvador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belgium | El Salvador | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 430 | 844.33 | 414.33 | El Salvador |
| 2020s | 348.5 | 418.5 | 70 | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Belgium or El Salvador?
- Belgium, at 377 against 316 in El Salvador as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Belgium and El Salvador?
- 61, with Belgium ahead.
- How many years of comparable data are there for Belgium and El Salvador?
- 5 years are reported by both, from 2017 to 2021.
- How do Belgium and El Salvador rank globally for the number of people with susceptibility test result for rifampicin?
- Belgium ranks 86th and El Salvador ranks 87th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.